The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.

Borrower

R•• H••••• S••••••• P•••

H•••••care & Pharmaceuticalsgroup grade Aoff every schedule since Mar 31, 2023sponsor unattributed
See every lender's markFind rescue capital
More
Special situations PE firms

Nothing material in the last 200 days. No dated change on record yet.

Principal held
at least $500,000
sum of BDC pieces, a lower bound
Fair value
-$3,000
n/a on cost, debt pieces
Unfunded
Not disclosed
commitments not yet drawn
BDC lenders
1
1 on the latest quarter
Facilities
1
0 equity pieces beside them
Next maturity
Aug 2, 2024
$500,000 inside 24 months
On the tape since
Mar 31, 2023
latest Mar 31, 2023
Events
2
dated, non-routine
Lender marks
each lender's own fair value over cost at Mar 31, 2023, folded to one row per lender
LenderExposureCurrent markQoQ change
M••••• F•••••••• I••••••••• C•••$500Kno cost filednew this quarter
Every BDC piece · 1 position across 1 lenderlargest principal first, with instrument and rate
BDCInstrumentPrincipalFair valueRate
M••••• F•••••••• I••••••••• C•••revolver first lien
F•••• L••• S•••••• D••• - R••••••• Investment T••• F•••• L••• S•••••• D••• I••••••• R••••+
$500,000-$3,000S+450 bp
Capital structure as the BDCs see it
latest quarter end Mar 31, 2023
FacilityHeldOn costPricingMaturityBDCs
first lien revolver first lien
exited Mar 31, 2023
at least $500,000n/aS+450 bpAug 2, 20241
Through time
the borrower's pieces summed across BDCs, every quarter end
Quarter endBDCsPrincipal heldFair valueOn costPIK pieces
Mar 31, 20231$500,000-$3,000n/a0
What changed
Every change including routine ones
Identity
Group key
R•• H••••• S••••••• P•••derivedthe codename stem after legal suffixes and deal words
Spellings
1 across 1 BDCderived
Industry
H•••••care & Pharmaceuticalsreportedas one filer wrote it